Clik here to view.
Vibegron, MK-4618 for for the treatment of overactive bladder
Vibegron, MK-4618 UNII-M5TSE03W5U; M5TSE03W5U; D10433 1190389-15-1; cas no Molecular Formula: C26H28N4O3 Molecular Weight: 444.52552 Merck Sharp & Dohme Corp. INNOVATOR phase 2 for the...
View ArticleClik here to view.
PRI-724, ICG 001, What is correct structure?
PRI 724 AND ICG001 do confuse us, my efforts to unlock this confusion STRUCTURE 4 4-(((6S,9S,9aS)-l-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)octahydro- 1 H-pyrazino[2, 1...
View ArticleClik here to view.
K 912, NC 6300, Epirubicin nano
Epirubicin Cancer Research UK Epirubicin Irish Cancer Society Epirubicin Macmillan Cancer Support Epirubicin NHS Evidence Epirubicin – Substance Summary PubChem EpirubicinEmail MedlinePlus – See...
View ArticleClik here to view.
Firategrast, T-0047
Japan Firategrast, 402567-16-2; Firategrast, MS, Alpha4beta1 integrin PHASE 2 GSK Mitsubishi Tanabe Pharma INNOVATOR Tanabe Seiyaku Co Glaxo Group Limited, Mitsubishi Tanabe Pharma Corporation SB...
View ArticleClik here to view.
MARIZEV® (Omarigliptin), Merck’s Once-Weekly DPP-4 Inhibitor for Type 2...
MARIZEV® (Omarigliptin), Merck’s Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and...
View ArticleClik here to view.
Fosfluconazole
Fosfluconazole Fosfluconazole; 194798-83-9; UNII-3JIJ299EWH; 3JIJ299EWH; NCGC00182029-01; 2-(2,4-difluorophenyl)-1,3-di(1h-1,2,4-triazol-1-yl)propan-2-yl dihydrogen phosphate;...
View ArticleClik here to view.
Trelagliptin
Trelagliptin 865759-25-7; UNII-Q836OWG55H Molecular Formula: C18H20FN5O2 Molecular Weight: 357.382103 g/mol...
View ArticleClik here to view.
Vonoprazan Fumarate
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate Vonoprazan Fumarate (Takecab®) Approved Vonoprazan Fumarate CAS#: 1260141-27-2 (fumarate); 881681-00-1...
View ArticleClik here to view.
Pemafibrate
Pemafibrate NDA Filing Japan, Phase 2 in EU, US A PPAR-α agonist potentially for the treatment of dyslipidemia. K-877, K-13675, (R)- CAS No. 848259-27-8, Molecular Formula,C28-H30-N2-O6,Molecular...
View ArticleClik here to view.
Imidafenacin, イミダフェナシン
Imidafenacin イミダフェナシン Cas 170105-16-5 C20H21N3O, 319.408 APPROVED JAPAN 2015-07-29 4-(2-methyl-1H-imidazol-1-yl)-2,2-diphenylbutanamide 4-(2-methylimidazol-1-yl)-2,2-di(phenyl)butyramide D06273...
View Article